Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Cui, Yiwen ^a   Masaki, Katsuhisa ^a   Yamasaki, Ryo ^a   Imamura, Shihoko ^a   Suzuki, Satoshi O ^a   Hayashi, Shintaro ^a   Sato, Shinya ^a   Nagara, Yuko ^a   Kawamura, Mami F ^a   Kira, Jun ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

amyotrophic lateral sclerosis; astrocyte; connexin; gap junction; oligodendrocyte; superoxide dismutase 1

Indexed keywords

AQUAPORIN 4; CONNEXIN 30; CONNEXIN 32; CONNEXIN 43; CONNEXIN 47; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN NOGO A;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; IMMUNOBLOTTING; IMMUNOREACTIVITY; LUMBAR SPINAL CORD; MALE; MICROGLIA; MOTONEURON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AQUAPORIN 4; ASTROCYTES; CONNEXINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; OLIGODENDROGLIA; RNA, MESSENGER; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 84898599002     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-42     Document Type: Article

References (38)

1. Boillée S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392. 10.1126/science.1123511, 16741123.
2. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008, 11:251-253. 10.1038/nn2047, 3137510, 18246065.
3. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2006, 24:16021-16026.
4. Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, Rao M, Eagle A, Kammesheidt A, Christensen A, Mendell JR, Burghes AH, Kaspar BK. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 2011, 29:824-828. 10.1038/nbt.1957, 3170425, 21832997.
5. Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012, 485:517-521. 3613737, 22622581.
6. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW, Pellerin L, Magistretti PJ, Rothstein JD. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012, 487:443-448. 10.1038/nature11314, 3408792, 22801498.
7. Philips T, Bento-Abreu A, Nonneman A, Haeck W, Staats K, Geelen V, Hersmus N, Küsters B, Van Den Bosch L, Van Damme P, Richardson WD, Robberecht W. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain 2013, 136:471-482. 10.1093/brain/aws339, 3572934, 23378219.
8. Orthmann-Murphy JL, Abrams CK, Scherer SS. Gap junctions couple astrocytes and oligodendrocytes. J Mol Neurosci 2008, 35:101-116. 10.1007/s12031-007-9027-5, 2650399, 18236012.
9. Orellana JA, Sáez PJ, Shoji KF, Schalper KA, Palacios-Prado N, Velarde V, Giaume C, Bennett MV, Sáez JC. Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid Redox Signal 2009, 11:369-399. 10.1089/ars.2008.2130, 2713807,2713807, 18816186.
10. Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008, 322:1551-1555. 10.1126/science.1164022, 19056987.
11. Díaz-Amarilla P, Olivera-Bravo S, Trias E, Cragnolini A, Martínez-Palma L, Cassina P, Beckman J, Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2011, 108:18126-18131. 10.1073/pnas.1110689108, 3207668, 22010221.
12. Masaki K, Suzuki SO, Matsushita T, Matsuoka T, Imamura S, Yamasaki R, Suzuki M, Suenaga T, Iwaki T, Kira J. Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica. PLoS One 2013, 8:e72919. 10.1371/journal.pone.0072919, 3749992, 23991165.
13. Markoullis K, Sargiannidou I, Schiza N, Hadjisavvas A, Roncaroli F, Reynolds R, Kleopa KA. Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol 2012, 123:873-886. 10.1007/s00401-012-0978-4, 22484441.
14. Markoullis K, Sargiannidou I, Gardner C, Hadjisavvas A, Reynolds R, Kleopa KA. Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis. Glia 2011, 60:1053-1066.
15. Nagy JI, Li W, Hertzberg EL, Marotta CA. Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res 1996, 717:173-178. 10.1016/0006-8993(95)01526-4, 8738268.
16. Mei X, Ezan P, Giaume C, Koulakoff A. Astroglial connexin immunoreactivity is specifically altered at β-amyloid plaques in β-amyloid precursor protein/presenilin1 mice. Neuroscience 2010, 171:92-105. 10.1016/j.neuroscience.2010.08.001, 20813165.
17. Rufer M, Wirth SB, Hofer A, Dermietzel R, Pastor A, Kettenmann H, Unsicker K. Regulation of connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTPlesioned, FGF-2-treated parkinsonian mice. J Neurosci Res 1996, 46:606-617. 10.1002/(SICI)1097-4547(19961201)46:5<606::AID-JNR9>3.0.CO;2-N, 8951672.
18. Aronica E, Gorter JA, Jansen GH, Leenstra S, Yankaya B, Troost D. Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol 2001, 101:449-459.
19. Fonseca CG, Green CR, Nicholson LF. Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res 2002, 929:105-116. 10.1016/S0006-8993(01)03289-9, 11852037.
20. Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, Rothstein JD, Bergles DE. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 2013, 16:571-579. 10.1038/nn.3357, 3637847, 23542689.
21. Guo Y, Duan W, Li Z, Huang J, Yin Y, Zhang K, Wang Q, Zhang Z, Li C. Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice. FEBS Lett 2010, 584:1615-1622. 10.1016/j.febslet.2010.03.025, 20303959.
22. Stieber A, Gonatas JO, Gonatas NK. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1 (G93A) mutation of familial amyotrophic lateral sclerosis. J Neurol Sci 2000, 177:114-123. 10.1016/S0022-510X(00)00351-8, 10980307.
23. Kleopa KA, Orthmann JL, Enriquez A, Paul DL, Scherer SS. Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes. Glia 2004, 47:346-357. 10.1002/glia.20043, 15293232.
24. Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brännström T, Gredal O, Nilsson P, Marklund SL. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 2004, 127:73-88. 10.1093/brain/awh005, 14534160.
25. Chattopadhyay M, Valentine JS. Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal 2009, 11:1603-1614. 10.1089/ars.2009.2536, 2842589, 19271992.
26. Kuhlmann T, Remington L, Maruschak B, Owens T, Brück W. Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol 2007, 66:238-246. 10.1097/01.jnen.0000248559.83573.71, 17356385.
27. Takasaki C, Yamasaki M, Uchigashima M, Konno K, Yanagawa Y, Watanabe M. Cytochemical and cytological properties of perineuronal oligodendrocytes in the mouse cortex. Eur J Neurosci 2010, 32:1326-1336. 10.1111/j.1460-9568.2010.07377.x, 20846325.
28. Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL. Connexins are critical for normal myelination in the CNS. J Neurosci 2003, 23:5963-5973.
29. Garré JM, Retamal MA, Cassina P, Barbeito L, Bukauskas FF, Sáez JC, Bennett MV, Abudara V. FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels. Proc Natl Acad Sci USA 2010, 107:22659-22664. 10.1073/pnas.1013793107, 3012468, 21148774.
30. Sáez JC, Retamal MA, Basilio D, Bukauskas FF, Bennett MV. Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta 2005, 1711:215-224. 10.1016/j.bbamem.2005.01.014, 3617572, 15955306.
31. Gandelman M, Peluffo H, Beckman JS, Cassina P, Barbeito L. Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. J Neuroinflammation 2010, 7:1-9. 10.1186/1742-2094-7-1, 2819252, 20047691.
32. Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 2006, 25:5071-5082. 10.1038/sj.emboj.7601378, 1630421, 17036048.
33. Thompson RJ, Jackson MF, Olah ME, Rungta RL, Hines DJ, Beazely MA, MacDonald J, MacVicar BA. Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science 2008, 322:1555-1559. 10.1126/science.1165209, 19056988.
34. Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MV, Naus CC, Giaume C, Sáez JC. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem 2011, 118:826-840. 10.1111/j.1471-4159.2011.07210.x, 3108012, 21294731.
35. Cronin M, Anderson PN, Cook JE, Green CR, Becker DL. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol Cell Neurosci 2008, 39:152-160. 10.1016/j.mcn.2008.06.005, 18617007.
36. Davidson JO, Green CR, Nicholson LF, O'Carroll SJ, Fraser M, Bennet L, Gunn AJ. Connexin hemichannel blockade improves outcomes in a model of fetal ischemia. Ann Neurol 2012, 71:121-132. 10.1002/ana.22654, 22275258.
37. Karpuk N, Burkovetskaya M, Fritz T, Angle A, Kielian T. Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity. J Neurosci 2011, 31:414-425. 10.1523/JNEUROSCI.5247-10.2011, 3089986, 21228152.
38. Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, Li H, Zhou Y, Mori R, Yasuoka S, Li E, Parajuli B, Kawanokuchi J, Sonobe Y, Sato J, Yamanaka K, Sobue G, Mizuno T, Suzumura A. Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. PLoS One 2011, 6:e21108. 10.1371/journal.pone.0021108, 3119678, 21712989.